CVT-124: Began Phase I trial in healthy volunteers. The compound reduces sodium resorption in the kidney, promoting diuresis while sparing potassium. CVT expect

CV Therapeutics Inc., Palo Alto Product: CVT-124, adenosine A1 receptor antagonist Indication: Edema associated with congestive heart failure Status: Began Phase I trial in healthy volunteers. The co...